These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8224447)

  • 1. Neurotoxicity of nicotinamide derivatives: their role in the aetiology of Parkinson's disease.
    Willets JM; Lunec J; Williams AC; Griffiths HR
    Biochem Soc Trans; 1993 Aug; 21 ( Pt 3)(3):299S. PubMed ID: 8224447
    [No Abstract]   [Full Text] [Related]  

  • 2. D-beta-hydroxybutyrate protects dopaminergic SH-SY5Y cells in a rotenone model of Parkinson's disease.
    Imamura K; Takeshima T; Kashiwaya Y; Nakaso K; Nakashima K
    J Neurosci Res; 2006 Nov; 84(6):1376-84. PubMed ID: 16917840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rotenone neurotoxicity: a new window on environmental causes of Parkinson's disease and related brain amyloidoses.
    Trojanowski JQ
    Exp Neurol; 2003 Jan; 179(1):6-8. PubMed ID: 12504862
    [No Abstract]   [Full Text] [Related]  

  • 4. Sensitivity of zebrafish to environmental toxins implicated in Parkinson's disease.
    Bretaud S; Lee S; Guo S
    Neurotoxicol Teratol; 2004; 26(6):857-64. PubMed ID: 15451049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Manganese- and 1-methyl-4-phenylpyridinium-induced neurotoxicity display differences in morphological, electrophysiological and genome-wide alterations: implications for idiopathic Parkinson's disease.
    Mythri RB; Raghunath NR; Narwade SC; Pandareesh MDR; Sabitha KR; Aiyaz M; Chand B; Sule M; Ghosh K; Kumar S; Shankarappa B; Soundararajan S; Alladi PA; Purushottam M; Gayathri N; Deobagkar DD; Laxmi TR; Srinivas Bharath MM
    J Neurochem; 2017 Nov; 143(3):334-358. PubMed ID: 28801915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lessons from the rotenone model of Parkinson's disease.
    Greenamyre JT; Cannon JR; Drolet R; Mastroberardino PG
    Trends Pharmacol Sci; 2010 Apr; 31(4):141-2; author reply 142-3. PubMed ID: 20096940
    [No Abstract]   [Full Text] [Related]  

  • 7. Pretreatment with near-infrared light via light-emitting diode provides added benefit against rotenone- and MPP+-induced neurotoxicity.
    Ying R; Liang HL; Whelan HT; Eells JT; Wong-Riley MT
    Brain Res; 2008 Dec; 1243():167-73. PubMed ID: 18848925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential pattern of motor impairments in neurotoxic, environmental and inflammation-driven rat models of Parkinson's disease.
    Naughton C; Moriarty N; Feehan J; O'Toole D; Dowd E
    Behav Brain Res; 2016 Jan; 296():451-458. PubMed ID: 26393432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurotoxicity and the mechanisms of cell death in Parkinson's disease.
    Schapira AH
    Adv Neurol; 1996; 69():161-5. PubMed ID: 8615125
    [No Abstract]   [Full Text] [Related]  

  • 10. Epidemiology. Paths from pesticides to Parkinson's.
    Kamel F
    Science; 2013 Aug; 341(6147):722-3. PubMed ID: 23950519
    [No Abstract]   [Full Text] [Related]  

  • 11. Mitochondrial mechanisms of neurotoxicity.
    Nicklas WJ; Saporito M; Basma A; Geller HM; Heikkila RE
    Ann N Y Acad Sci; 1992 May; 648():28-36. PubMed ID: 1637057
    [No Abstract]   [Full Text] [Related]  

  • 12. L-Deprenyl prevents the cell hypoxia induced by dopaminergic neurotoxins, MPP(+) and beta-carbolinium: a microdialysis study in rats.
    Matsubara K; Senda T; Uezono T; Awaya T; Ogawa S; Chiba K; Shimizu K; Hayase N; Kimura K
    Neurosci Lett; 2001 Apr; 302(2-3):65-8. PubMed ID: 11290388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of the major transport pathway for the parkinsonism-inducing neurotoxin 1-methyl-4-phenylpyridinium.
    Dunigan CD; Shamoo AE
    Neuroscience; 1996 Nov; 75(1):37-41. PubMed ID: 8923521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurotoxic in vivo models of Parkinson's disease recent advances.
    Cannon JR; Greenamyre JT
    Prog Brain Res; 2010; 184():17-33. PubMed ID: 20887868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enteric Neurodegeneration is Mediated Through Independent Neuritic and Somal Mechanisms in Rotenone and MPP+ Toxicity.
    Virga DM; Capps J; Vohra BPS
    Neurochem Res; 2018 Dec; 43(12):2288-2303. PubMed ID: 30259276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SAG protects human neuroblastoma SH-SY5Y cells against 1-methyl-4-phenylpyridinium ion (MPP+)-induced cytotoxicity via the downregulation of ROS generation and JNK signaling.
    Kim SY; Kim MY; Mo JS; Park JW; Park HS
    Neurosci Lett; 2007 Feb; 413(2):132-6. PubMed ID: 17240529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemically induced Parkinson's disease: intermediates in the oxidation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine to the 1-methyl-4-phenyl-pyridinium ion.
    Chacon JN; Chedekel MR; Land EJ; Truscott TG
    Biochem Biophys Res Commun; 1987 Apr; 144(2):957-64. PubMed ID: 3495270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective dopaminergic neurotoxicity of isoquinoline derivatives related to Parkinson's disease: studies using heterologous expression systems of the dopamine transporter.
    Storch A; Ott S; Hwang YI; Ortmann R; Hein A; Frenzel S; Matsubara K; Ohta S; Wolf HU; Schwarz J
    Biochem Pharmacol; 2002 Mar; 63(5):909-20. PubMed ID: 11911843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurochemical responses to 6-hydroxydopamine and L-dopa therapy: implications for Parkinson's disease.
    Zigmond MJ; Hastings TG; Abercrombie ED
    Ann N Y Acad Sci; 1992 May; 648():71-86. PubMed ID: 1637074
    [No Abstract]   [Full Text] [Related]  

  • 20. MPTP and the aetiology of Parkinson's disease. Clinical implications. London, June 27, 1985.
    J Neural Transm Suppl; 1986; 20():1-81. PubMed ID: 3489069
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.